KDNY
T. Rowe Price Associates’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-15,944
| Closed | -$613K | – | 2938 |
|
|
2023
Q2 | $613K | Sell |
15,944
-12,378
| -44% | -$476K | ﹤0.01% | 2030 |
|
|
2023
Q1 | $657K | Buy |
28,322
+861
| +3% | +$20K | ﹤0.01% | 1991 |
|
|
2022
Q4 | $719K | Buy |
27,461
+1,035
| +4% | +$27.1K | ﹤0.01% | 1958 |
|
|
2022
Q3 | $520K | Buy |
+26,426
| New | +$520K | ﹤0.01% | 2102 |
|
|
2021
Q4 | – | Sell |
-11,893
| Closed | -$152K | – | 3057 |
|
|
2021
Q3 | $152K | Buy |
+11,893
| New | +$152K | ﹤0.01% | 2772 |
|
|
2015
Q3 | – | Sell |
-209,300
| Closed | -$6.35M | – | 2547 |
|
|
2015
Q2 | $6.35M | Buy |
+209,300
| New | +$6.35M | ﹤0.01% | 1437 |
|